nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP2D6—breast cancer	0.14	0.538	CbGaD
Cilostazol—CYP3A4—breast cancer	0.12	0.462	CbGaD
Cilostazol—CYP1A2—Anastrozole—breast cancer	0.0287	0.0614	CbGbCtD
Cilostazol—CYP1A2—Toremifene—breast cancer	0.0262	0.0561	CbGbCtD
Cilostazol—CYP3A5—Lapatinib—breast cancer	0.0257	0.055	CbGbCtD
Cilostazol—CYP2C19—Lapatinib—breast cancer	0.0207	0.0444	CbGbCtD
Cilostazol—CYP3A4—Exemestane—breast cancer	0.0198	0.0424	CbGbCtD
Cilostazol—CYP2D6—Idarubicin—breast cancer	0.0179	0.0383	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0172	0.0367	CbGbCtD
Cilostazol—CYP3A7—Tamoxifen—breast cancer	0.0172	0.0367	CbGbCtD
Cilostazol—CYP3A4—Letrozole—breast cancer	0.0169	0.0361	CbGbCtD
Cilostazol—CYP3A4—Anastrozole—breast cancer	0.015	0.0321	CbGbCtD
Cilostazol—CYP3A4—Toremifene—breast cancer	0.0137	0.0294	CbGbCtD
Cilostazol—CYP3A7—Paclitaxel—breast cancer	0.0134	0.0286	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0134	0.0286	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0132	0.0282	CbGbCtD
Cilostazol—CYP3A7—Irinotecan—breast cancer	0.0132	0.0282	CbGbCtD
Cilostazol—CYP3A5—Tamoxifen—breast cancer	0.0129	0.0275	CbGbCtD
Cilostazol—CYP3A4—Fulvestrant—breast cancer	0.0128	0.0273	CbGbCtD
Cilostazol—CYP3A4—Thiotepa—breast cancer	0.0114	0.0244	CbGbCtD
Cilostazol—CYP3A4—Ixabepilone—breast cancer	0.0104	0.0223	CbGbCtD
Cilostazol—CYP2C19—Tamoxifen—breast cancer	0.0104	0.0222	CbGbCtD
Cilostazol—CYP3A4—Lapatinib—breast cancer	0.01	0.0214	CbGbCtD
Cilostazol—CYP3A5—Paclitaxel—breast cancer	0.01	0.0214	CbGbCtD
Cilostazol—CYP3A5—Irinotecan—breast cancer	0.00989	0.0211	CbGbCtD
Cilostazol—CYP3A7—Docetaxel—breast cancer	0.00966	0.0207	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00966	0.0207	CbGbCtD
Cilostazol—CYP1A2—Tamoxifen—breast cancer	0.00958	0.0205	CbGbCtD
Cilostazol—CYP2D6—Vinorelbine—breast cancer	0.00875	0.0187	CbGbCtD
Cilostazol—CYP2D6—Tamoxifen—breast cancer	0.00789	0.0169	CbGbCtD
Cilostazol—CYP3A4—Raloxifene—breast cancer	0.0076	0.0163	CbGbCtD
Cilostazol—CYP3A5—Docetaxel—breast cancer	0.00724	0.0155	CbGbCtD
Cilostazol—CYP1A2—Fluorouracil—breast cancer	0.00706	0.0151	CbGbCtD
Cilostazol—CYP3A4—Vinorelbine—breast cancer	0.00556	0.0119	CbGbCtD
Cilostazol—CYP2D6—Vinblastine—breast cancer	0.00539	0.0115	CbGbCtD
Cilostazol—CYP3A4—Tamoxifen—breast cancer	0.00502	0.0107	CbGbCtD
Cilostazol—CYP3A4—Mitoxantrone—breast cancer	0.0049	0.0105	CbGbCtD
Cilostazol—CYP3A4—Paclitaxel—breast cancer	0.00391	0.00836	CbGbCtD
Cilostazol—CYP3A4—Irinotecan—breast cancer	0.00385	0.00825	CbGbCtD
Cilostazol—CYP3A4—Vinblastine—breast cancer	0.00343	0.00733	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—breast cancer	0.00331	0.00708	CbGbCtD
Cilostazol—CYP3A4—Docetaxel—breast cancer	0.00282	0.00604	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—breast cancer	0.00211	0.0045	CbGbCtD
Cilostazol—Aripiprazole—CYP2D6—breast cancer	0.000152	0.389	CrCbGaD
Cilostazol—Aripiprazole—CYP3A4—breast cancer	0.000131	0.333	CrCbGaD
Cilostazol—Aripiprazole—ABCB1—breast cancer	0.000109	0.278	CrCbGaD
Cilostazol—Hypoaesthesia—Epirubicin—breast cancer	3.59e-05	0.000178	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—breast cancer	3.58e-05	0.000177	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—breast cancer	3.58e-05	0.000177	CcSEcCtD
Cilostazol—Skin disorder—Capecitabine—breast cancer	3.57e-05	0.000177	CcSEcCtD
Cilostazol—Urticaria—Paclitaxel—breast cancer	3.56e-05	0.000176	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—breast cancer	3.55e-05	0.000176	CcSEcCtD
Cilostazol—Hypotension—Docetaxel—breast cancer	3.55e-05	0.000176	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—breast cancer	3.54e-05	0.000175	CcSEcCtD
Cilostazol—Abdominal pain—Paclitaxel—breast cancer	3.54e-05	0.000175	CcSEcCtD
Cilostazol—Body temperature increased—Paclitaxel—breast cancer	3.54e-05	0.000175	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—breast cancer	3.52e-05	0.000174	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—breast cancer	3.51e-05	0.000173	CcSEcCtD
Cilostazol—Anorexia—Capecitabine—breast cancer	3.51e-05	0.000173	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—breast cancer	3.5e-05	0.000173	CcSEcCtD
Cilostazol—Vomiting—Irinotecan—breast cancer	3.49e-05	0.000173	CcSEcCtD
Cilostazol—Vomiting—Mitoxantrone—breast cancer	3.49e-05	0.000173	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—breast cancer	3.49e-05	0.000173	CcSEcCtD
Cilostazol—Dizziness—Fluorouracil—breast cancer	3.48e-05	0.000172	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—breast cancer	3.47e-05	0.000172	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—breast cancer	3.47e-05	0.000172	CcSEcCtD
Cilostazol—Rash—Mitoxantrone—breast cancer	3.47e-05	0.000171	CcSEcCtD
Cilostazol—Rash—Irinotecan—breast cancer	3.47e-05	0.000171	CcSEcCtD
Cilostazol—Dermatitis—Mitoxantrone—breast cancer	3.46e-05	0.000171	CcSEcCtD
Cilostazol—Dermatitis—Irinotecan—breast cancer	3.46e-05	0.000171	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Docetaxel—breast cancer	3.46e-05	0.000171	CcSEcCtD
Cilostazol—Chills—Methotrexate—breast cancer	3.46e-05	0.000171	CcSEcCtD
Cilostazol—Headache—Mitoxantrone—breast cancer	3.44e-05	0.00017	CcSEcCtD
Cilostazol—Headache—Irinotecan—breast cancer	3.44e-05	0.00017	CcSEcCtD
Cilostazol—Hypotension—Capecitabine—breast cancer	3.44e-05	0.00017	CcSEcCtD
Cilostazol—Insomnia—Docetaxel—breast cancer	3.44e-05	0.00017	CcSEcCtD
Cilostazol—Paraesthesia—Docetaxel—breast cancer	3.41e-05	0.000169	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—breast cancer	3.41e-05	0.000169	CcSEcCtD
Cilostazol—Vomiting—Gemcitabine—breast cancer	3.4e-05	0.000168	CcSEcCtD
Cilostazol—Dyspnoea—Docetaxel—breast cancer	3.39e-05	0.000168	CcSEcCtD
Cilostazol—Rash—Gemcitabine—breast cancer	3.38e-05	0.000167	CcSEcCtD
Cilostazol—Dermatitis—Gemcitabine—breast cancer	3.37e-05	0.000167	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—breast cancer	3.36e-05	0.000166	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Headache—Gemcitabine—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Capecitabine—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Vomiting—Fluorouracil—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—breast cancer	3.35e-05	0.000166	CcSEcCtD
Cilostazol—Dyspepsia—Docetaxel—breast cancer	3.34e-05	0.000165	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—breast cancer	3.34e-05	0.000165	CcSEcCtD
Cilostazol—Insomnia—Capecitabine—breast cancer	3.33e-05	0.000165	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—breast cancer	3.32e-05	0.000164	CcSEcCtD
Cilostazol—Rash—Fluorouracil—breast cancer	3.32e-05	0.000164	CcSEcCtD
Cilostazol—Dermatitis—Fluorouracil—breast cancer	3.32e-05	0.000164	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—breast cancer	3.31e-05	0.000164	CcSEcCtD
Cilostazol—Paraesthesia—Capecitabine—breast cancer	3.3e-05	0.000163	CcSEcCtD
Cilostazol—Decreased appetite—Docetaxel—breast cancer	3.3e-05	0.000163	CcSEcCtD
Cilostazol—Headache—Fluorouracil—breast cancer	3.3e-05	0.000163	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—breast cancer	3.29e-05	0.000163	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Docetaxel—breast cancer	3.28e-05	0.000162	CcSEcCtD
Cilostazol—Dyspnoea—Capecitabine—breast cancer	3.28e-05	0.000162	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—breast cancer	3.27e-05	0.000162	CcSEcCtD
Cilostazol—Nausea—Mitoxantrone—breast cancer	3.26e-05	0.000161	CcSEcCtD
Cilostazol—Nausea—Irinotecan—breast cancer	3.26e-05	0.000161	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—breast cancer	3.25e-05	0.000161	CcSEcCtD
Cilostazol—Pain—Docetaxel—breast cancer	3.25e-05	0.000161	CcSEcCtD
Cilostazol—Back pain—Methotrexate—breast cancer	3.25e-05	0.000161	CcSEcCtD
Cilostazol—Dyspepsia—Capecitabine—breast cancer	3.24e-05	0.00016	CcSEcCtD
Cilostazol—Chills—Epirubicin—breast cancer	3.24e-05	0.00016	CcSEcCtD
Cilostazol—Asthenia—Paclitaxel—breast cancer	3.22e-05	0.000159	CcSEcCtD
Cilostazol—Decreased appetite—Capecitabine—breast cancer	3.2e-05	0.000158	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—breast cancer	3.18e-05	0.000157	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Capecitabine—breast cancer	3.18e-05	0.000157	CcSEcCtD
Cilostazol—Pruritus—Paclitaxel—breast cancer	3.17e-05	0.000157	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—breast cancer	3.16e-05	0.000156	CcSEcCtD
Cilostazol—Pain—Capecitabine—breast cancer	3.15e-05	0.000156	CcSEcCtD
Cilostazol—Feeling abnormal—Docetaxel—breast cancer	3.13e-05	0.000155	CcSEcCtD
Cilostazol—Nausea—Fluorouracil—breast cancer	3.13e-05	0.000155	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—breast cancer	3.11e-05	0.000154	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—breast cancer	3.11e-05	0.000154	CcSEcCtD
Cilostazol—Gastrointestinal pain—Docetaxel—breast cancer	3.11e-05	0.000154	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—breast cancer	3.1e-05	0.000153	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—breast cancer	3.1e-05	0.000153	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—breast cancer	3.09e-05	0.000153	CcSEcCtD
Cilostazol—Diarrhoea—Paclitaxel—breast cancer	3.07e-05	0.000152	CcSEcCtD
Cilostazol—Back pain—Epirubicin—breast cancer	3.04e-05	0.00015	CcSEcCtD
Cilostazol—Feeling abnormal—Capecitabine—breast cancer	3.03e-05	0.00015	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—breast cancer	3.03e-05	0.00015	CcSEcCtD
Cilostazol—Malaise—Methotrexate—breast cancer	3.03e-05	0.00015	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—breast cancer	3.02e-05	0.000149	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—breast cancer	3.01e-05	0.000149	CcSEcCtD
Cilostazol—Gastrointestinal pain—Capecitabine—breast cancer	3.01e-05	0.000149	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—breast cancer	3.01e-05	0.000149	CcSEcCtD
Cilostazol—Body temperature increased—Docetaxel—breast cancer	3e-05	0.000149	CcSEcCtD
Cilostazol—Abdominal pain—Docetaxel—breast cancer	3e-05	0.000149	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—breast cancer	3e-05	0.000149	CcSEcCtD
Cilostazol—Chills—Doxorubicin—breast cancer	2.99e-05	0.000148	CcSEcCtD
Cilostazol—Dizziness—Paclitaxel—breast cancer	2.96e-05	0.000147	CcSEcCtD
Cilostazol—Cough—Methotrexate—breast cancer	2.93e-05	0.000145	CcSEcCtD
Cilostazol—Urticaria—Capecitabine—breast cancer	2.92e-05	0.000145	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—breast cancer	2.91e-05	0.000144	CcSEcCtD
Cilostazol—Body temperature increased—Capecitabine—breast cancer	2.91e-05	0.000144	CcSEcCtD
Cilostazol—Abdominal pain—Capecitabine—breast cancer	2.91e-05	0.000144	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—breast cancer	2.9e-05	0.000144	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—breast cancer	2.86e-05	0.000142	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—breast cancer	2.86e-05	0.000141	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—breast cancer	2.86e-05	0.000141	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—breast cancer	2.86e-05	0.000141	CcSEcCtD
Cilostazol—Vomiting—Paclitaxel—breast cancer	2.85e-05	0.000141	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.84e-05	0.00014	CcSEcCtD
Cilostazol—Malaise—Epirubicin—breast cancer	2.83e-05	0.00014	CcSEcCtD
Cilostazol—Rash—Paclitaxel—breast cancer	2.83e-05	0.00014	CcSEcCtD
Cilostazol—Dermatitis—Paclitaxel—breast cancer	2.82e-05	0.00014	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—breast cancer	2.82e-05	0.00014	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—breast cancer	2.82e-05	0.00014	CcSEcCtD
Cilostazol—Syncope—Epirubicin—breast cancer	2.82e-05	0.000139	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—breast cancer	2.81e-05	0.000139	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—breast cancer	2.81e-05	0.000139	CcSEcCtD
Cilostazol—Headache—Paclitaxel—breast cancer	2.81e-05	0.000139	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—breast cancer	2.79e-05	0.000138	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—breast cancer	2.77e-05	0.000137	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—breast cancer	2.76e-05	0.000137	CcSEcCtD
Cilostazol—Cough—Epirubicin—breast cancer	2.74e-05	0.000136	CcSEcCtD
Cilostazol—Asthenia—Docetaxel—breast cancer	2.73e-05	0.000135	CcSEcCtD
Cilostazol—Infection—Methotrexate—breast cancer	2.72e-05	0.000135	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—breast cancer	2.71e-05	0.000134	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—breast cancer	2.7e-05	0.000133	CcSEcCtD
Cilostazol—Pruritus—Docetaxel—breast cancer	2.69e-05	0.000133	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—breast cancer	2.69e-05	0.000133	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—breast cancer	2.69e-05	0.000133	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—breast cancer	2.68e-05	0.000133	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—breast cancer	2.67e-05	0.000132	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—breast cancer	2.67e-05	0.000132	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—breast cancer	2.67e-05	0.000132	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—breast cancer	2.66e-05	0.000132	CcSEcCtD
Cilostazol—Nausea—Paclitaxel—breast cancer	2.66e-05	0.000132	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—breast cancer	2.66e-05	0.000132	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.65e-05	0.000131	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—breast cancer	2.64e-05	0.000131	CcSEcCtD
Cilostazol—Asthenia—Capecitabine—breast cancer	2.64e-05	0.000131	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—breast cancer	2.62e-05	0.00013	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—breast cancer	2.61e-05	0.000129	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—breast cancer	2.61e-05	0.000129	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—breast cancer	2.61e-05	0.000129	CcSEcCtD
Cilostazol—Pruritus—Capecitabine—breast cancer	2.6e-05	0.000129	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—breast cancer	2.6e-05	0.000129	CcSEcCtD
Cilostazol—Diarrhoea—Docetaxel—breast cancer	2.6e-05	0.000129	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—breast cancer	2.57e-05	0.000127	CcSEcCtD
Cilostazol—Oedema—Epirubicin—breast cancer	2.56e-05	0.000127	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—breast cancer	2.56e-05	0.000127	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—breast cancer	2.55e-05	0.000126	CcSEcCtD
Cilostazol—Infection—Epirubicin—breast cancer	2.55e-05	0.000126	CcSEcCtD
Cilostazol—Cough—Doxorubicin—breast cancer	2.54e-05	0.000125	CcSEcCtD
Cilostazol—Shock—Epirubicin—breast cancer	2.52e-05	0.000125	CcSEcCtD
Cilostazol—Diarrhoea—Capecitabine—breast cancer	2.52e-05	0.000124	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—breast cancer	2.51e-05	0.000124	CcSEcCtD
Cilostazol—Dizziness—Docetaxel—breast cancer	2.51e-05	0.000124	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—breast cancer	2.51e-05	0.000124	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—breast cancer	2.51e-05	0.000124	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—breast cancer	2.5e-05	0.000124	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—breast cancer	2.49e-05	0.000123	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—breast cancer	2.49e-05	0.000123	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—breast cancer	2.48e-05	0.000123	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—breast cancer	2.47e-05	0.000122	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—breast cancer	2.47e-05	0.000122	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—breast cancer	2.47e-05	0.000122	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—breast cancer	2.46e-05	0.000122	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—breast cancer	2.46e-05	0.000122	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.46e-05	0.000122	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—breast cancer	2.44e-05	0.000121	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—breast cancer	2.44e-05	0.000121	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—breast cancer	2.44e-05	0.000121	CcSEcCtD
Cilostazol—Dizziness—Capecitabine—breast cancer	2.43e-05	0.00012	CcSEcCtD
Cilostazol—Vomiting—Docetaxel—breast cancer	2.42e-05	0.000119	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—breast cancer	2.41e-05	0.000119	CcSEcCtD
Cilostazol—Rash—Docetaxel—breast cancer	2.4e-05	0.000118	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—breast cancer	2.39e-05	0.000118	CcSEcCtD
Cilostazol—Dermatitis—Docetaxel—breast cancer	2.39e-05	0.000118	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—breast cancer	2.38e-05	0.000118	CcSEcCtD
Cilostazol—Headache—Docetaxel—breast cancer	2.38e-05	0.000118	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—breast cancer	2.37e-05	0.000117	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—breast cancer	2.36e-05	0.000117	CcSEcCtD
Cilostazol—Infection—Doxorubicin—breast cancer	2.36e-05	0.000117	CcSEcCtD
Cilostazol—Pain—Methotrexate—breast cancer	2.34e-05	0.000116	CcSEcCtD
Cilostazol—Vomiting—Capecitabine—breast cancer	2.34e-05	0.000116	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—breast cancer	2.33e-05	0.000115	CcSEcCtD
Cilostazol—Shock—Doxorubicin—breast cancer	2.33e-05	0.000115	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—breast cancer	2.33e-05	0.000115	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—breast cancer	2.32e-05	0.000115	CcSEcCtD
Cilostazol—Rash—Capecitabine—breast cancer	2.32e-05	0.000115	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—breast cancer	2.32e-05	0.000115	CcSEcCtD
Cilostazol—Dermatitis—Capecitabine—breast cancer	2.32e-05	0.000115	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—breast cancer	2.31e-05	0.000114	CcSEcCtD
Cilostazol—Headache—Capecitabine—breast cancer	2.3e-05	0.000114	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—breast cancer	2.3e-05	0.000114	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—breast cancer	2.3e-05	0.000114	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—breast cancer	2.28e-05	0.000113	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—breast cancer	2.26e-05	0.000112	CcSEcCtD
Cilostazol—Nausea—Docetaxel—breast cancer	2.26e-05	0.000112	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—breast cancer	2.26e-05	0.000112	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—breast cancer	2.26e-05	0.000112	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—breast cancer	2.24e-05	0.000111	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—breast cancer	2.23e-05	0.00011	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—breast cancer	2.22e-05	0.00011	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—breast cancer	2.21e-05	0.000109	CcSEcCtD
Cilostazol—Pain—Epirubicin—breast cancer	2.19e-05	0.000108	CcSEcCtD
Cilostazol—Nausea—Capecitabine—breast cancer	2.18e-05	0.000108	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—breast cancer	2.18e-05	0.000108	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—breast cancer	2.16e-05	0.000107	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—breast cancer	2.16e-05	0.000107	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.16e-05	0.000107	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—breast cancer	2.14e-05	0.000106	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—breast cancer	2.13e-05	0.000105	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—breast cancer	2.11e-05	0.000105	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—breast cancer	2.11e-05	0.000104	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—breast cancer	2.1e-05	0.000104	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—breast cancer	2.09e-05	0.000103	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—breast cancer	2.06e-05	0.000102	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—breast cancer	2.05e-05	0.000101	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—breast cancer	2.04e-05	0.000101	CcSEcCtD
Cilostazol—Pain—Doxorubicin—breast cancer	2.03e-05	0.0001	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—breast cancer	2.03e-05	0.0001	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—breast cancer	2.03e-05	0.0001	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—breast cancer	1.96e-05	9.72e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—breast cancer	1.95e-05	9.67e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—breast cancer	1.94e-05	9.59e-05	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—breast cancer	1.94e-05	9.58e-05	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—breast cancer	1.88e-05	9.32e-05	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—breast cancer	1.87e-05	9.27e-05	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—breast cancer	1.87e-05	9.27e-05	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—breast cancer	1.87e-05	9.27e-05	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—breast cancer	1.84e-05	9.09e-05	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—breast cancer	1.81e-05	8.97e-05	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—breast cancer	1.81e-05	8.96e-05	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—breast cancer	1.75e-05	8.67e-05	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—breast cancer	1.74e-05	8.61e-05	CcSEcCtD
Cilostazol—Rash—Methotrexate—breast cancer	1.73e-05	8.54e-05	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—breast cancer	1.72e-05	8.53e-05	CcSEcCtD
Cilostazol—Headache—Methotrexate—breast cancer	1.72e-05	8.49e-05	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—breast cancer	1.7e-05	8.42e-05	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—breast cancer	1.69e-05	8.38e-05	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—breast cancer	1.68e-05	8.3e-05	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—breast cancer	1.63e-05	8.06e-05	CcSEcCtD
Cilostazol—Nausea—Methotrexate—breast cancer	1.63e-05	8.05e-05	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—breast cancer	1.62e-05	8.03e-05	CcSEcCtD
Cilostazol—Rash—Epirubicin—breast cancer	1.62e-05	7.99e-05	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—breast cancer	1.61e-05	7.99e-05	CcSEcCtD
Cilostazol—Headache—Epirubicin—breast cancer	1.61e-05	7.94e-05	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—breast cancer	1.57e-05	7.76e-05	CcSEcCtD
Cilostazol—Nausea—Epirubicin—breast cancer	1.52e-05	7.53e-05	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—breast cancer	1.51e-05	7.46e-05	CcSEcCtD
Cilostazol—Rash—Doxorubicin—breast cancer	1.49e-05	7.4e-05	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—breast cancer	1.49e-05	7.39e-05	CcSEcCtD
Cilostazol—Headache—Doxorubicin—breast cancer	1.49e-05	7.35e-05	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—breast cancer	1.41e-05	6.97e-05	CcSEcCtD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.3e-06	7.64e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CAV1—breast cancer	5.28e-06	7.6e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.24e-06	7.54e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ACHE—breast cancer	5.23e-06	7.53e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—breast cancer	5.23e-06	7.53e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2D6—breast cancer	5.22e-06	7.52e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—breast cancer	5.21e-06	7.51e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCC1—breast cancer	5.18e-06	7.46e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMMR—breast cancer	5.18e-06	7.46e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA3—breast cancer	5.18e-06	7.46e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.16e-06	7.43e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA2—breast cancer	5.13e-06	7.38e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—COMT—breast cancer	5.12e-06	7.37e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—breast cancer	5.09e-06	7.34e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—breast cancer	5.08e-06	7.31e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—breast cancer	5.03e-06	7.24e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—breast cancer	5.02e-06	7.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.02e-06	7.23e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ITPR1—breast cancer	5.01e-06	7.22e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—DPYD—breast cancer	5.01e-06	7.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MED12—breast cancer	5.01e-06	7.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—FASN—breast cancer	4.97e-06	7.16e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BCHE—breast cancer	4.95e-06	7.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP17A1—breast cancer	4.95e-06	7.12e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDOA—breast cancer	4.93e-06	7.1e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS1—breast cancer	4.9e-06	7.05e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO1—breast cancer	4.9e-06	7.05e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC5A5—breast cancer	4.89e-06	7.04e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—breast cancer	4.82e-06	6.94e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—breast cancer	4.81e-06	6.92e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK3—breast cancer	4.8e-06	6.91e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA3—breast cancer	4.78e-06	6.89e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A2—breast cancer	4.75e-06	6.84e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA4—breast cancer	4.74e-06	6.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA9—breast cancer	4.74e-06	6.83e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMS—breast cancer	4.74e-06	6.82e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—breast cancer	4.72e-06	6.8e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC2A1—breast cancer	4.72e-06	6.8e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA2—breast cancer	4.71e-06	6.79e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.7e-06	6.77e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—breast cancer	4.68e-06	6.74e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NCOR1—breast cancer	4.68e-06	6.74e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.68e-06	6.74e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—breast cancer	4.67e-06	6.73e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—breast cancer	4.66e-06	6.71e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CPT1A—breast cancer	4.65e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCG2—breast cancer	4.65e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTR—breast cancer	4.65e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.62e-06	6.66e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA2—breast cancer	4.62e-06	6.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX2—breast cancer	4.62e-06	6.65e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP3A4—breast cancer	4.6e-06	6.63e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.58e-06	6.6e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—FASN—breast cancer	4.57e-06	6.58e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—breast cancer	4.57e-06	6.58e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HPGDS—breast cancer	4.56e-06	6.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX4—breast cancer	4.56e-06	6.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SULT1A1—breast cancer	4.56e-06	6.57e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BCHE—breast cancer	4.55e-06	6.56e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HBA1—breast cancer	4.54e-06	6.53e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1B1—breast cancer	4.53e-06	6.52e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC5A5—breast cancer	4.5e-06	6.48e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—breast cancer	4.48e-06	6.46e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA1—breast cancer	4.46e-06	6.42e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH1—breast cancer	4.46e-06	6.42e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.44e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—breast cancer	4.44e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACHE—breast cancer	4.43e-06	6.37e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—breast cancer	4.43e-06	6.37e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAT2—breast cancer	4.41e-06	6.35e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ERCC2—breast cancer	4.4e-06	6.34e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A1—breast cancer	4.34e-06	6.25e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—breast cancer	4.34e-06	6.25e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA1—breast cancer	4.32e-06	6.22e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—breast cancer	4.32e-06	6.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—STK11—breast cancer	4.26e-06	6.13e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP19A1—breast cancer	4.26e-06	6.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP3A4—breast cancer	4.24e-06	6.1e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—breast cancer	4.23e-06	6.09e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP17A1—breast cancer	4.19e-06	6.03e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—breast cancer	4.17e-06	6.01e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1B1—breast cancer	4.16e-06	6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS1—breast cancer	4.15e-06	5.97e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO1—breast cancer	4.15e-06	5.97e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—breast cancer	4.14e-06	5.96e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.13e-06	5.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.08e-06	5.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.08e-06	5.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2D6—breast cancer	4.07e-06	5.86e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4e-06	5.75e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA2—breast cancer	3.99e-06	5.75e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NOS3—breast cancer	3.99e-06	5.75e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA1—breast cancer	3.97e-06	5.72e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—breast cancer	3.97e-06	5.71e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—COMT—breast cancer	3.96e-06	5.7e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—breast cancer	3.94e-06	5.67e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP19A1—breast cancer	3.91e-06	5.64e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—STK11—breast cancer	3.91e-06	5.64e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—breast cancer	3.88e-06	5.59e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ITPR1—breast cancer	3.88e-06	5.58e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—FASN—breast cancer	3.87e-06	5.58e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MED12—breast cancer	3.86e-06	5.56e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—DPYD—breast cancer	3.86e-06	5.56e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BCHE—breast cancer	3.86e-06	5.55e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—breast cancer	3.84e-06	5.52e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAV1—breast cancer	3.82e-06	5.49e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC5A5—breast cancer	3.81e-06	5.49e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDOA—breast cancer	3.8e-06	5.48e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—breast cancer	3.73e-06	5.37e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA3—breast cancer	3.69e-06	5.32e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—breast cancer	3.68e-06	5.31e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—breast cancer	3.68e-06	5.3e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A1—breast cancer	3.68e-06	5.3e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HRAS—breast cancer	3.67e-06	5.28e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A2—breast cancer	3.67e-06	5.28e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMS—breast cancer	3.66e-06	5.27e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—breast cancer	3.65e-06	5.26e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—COMT—breast cancer	3.64e-06	5.24e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—breast cancer	3.62e-06	5.22e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.62e-06	5.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOR1—breast cancer	3.62e-06	5.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—breast cancer	3.62e-06	5.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.6e-06	5.19e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTR—breast cancer	3.59e-06	5.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CPT1A—breast cancer	3.59e-06	5.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCG2—breast cancer	3.59e-06	5.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP3A4—breast cancer	3.59e-06	5.17e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—breast cancer	3.57e-06	5.14e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.57e-06	5.14e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ITPR1—breast cancer	3.56e-06	5.13e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1B1—breast cancer	3.53e-06	5.08e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HPGDS—breast cancer	3.52e-06	5.07e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—breast cancer	3.51e-06	5.06e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HBA1—breast cancer	3.5e-06	5.04e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—breast cancer	3.48e-06	5.01e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—breast cancer	3.47e-06	4.99e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.46e-06	4.98e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—breast cancer	3.43e-06	4.94e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—breast cancer	3.43e-06	4.94e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—breast cancer	3.42e-06	4.92e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACHE—breast cancer	3.42e-06	4.92e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ERCC2—breast cancer	3.4e-06	4.9e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMS—breast cancer	3.37e-06	4.85e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA1—breast cancer	3.37e-06	4.85e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.33e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOR1—breast cancer	3.33e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—breast cancer	3.33e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—STK11—breast cancer	3.32e-06	4.78e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP19A1—breast cancer	3.32e-06	4.78e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—breast cancer	3.24e-06	4.66e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP17A1—breast cancer	3.23e-06	4.66e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS1—breast cancer	3.2e-06	4.61e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO1—breast cancer	3.2e-06	4.61e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—breast cancer	3.2e-06	4.61e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—breast cancer	3.19e-06	4.59e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—breast cancer	3.18e-06	4.58e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—breast cancer	3.16e-06	4.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2D6—breast cancer	3.14e-06	4.52e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ERCC2—breast cancer	3.13e-06	4.51e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.11e-06	4.48e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—COMT—breast cancer	3.08e-06	4.44e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA2—breast cancer	3.08e-06	4.44e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—breast cancer	3.07e-06	4.42e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—breast cancer	3.06e-06	4.4e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—breast cancer	3.03e-06	4.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ITPR1—breast cancer	3.02e-06	4.35e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—breast cancer	3.02e-06	4.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FASN—breast cancer	2.99e-06	4.3e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BCHE—breast cancer	2.98e-06	4.29e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAV1—breast cancer	2.95e-06	4.25e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—breast cancer	2.94e-06	4.24e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A5—breast cancer	2.94e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—breast cancer	2.9e-06	4.18e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NOS3—breast cancer	2.89e-06	4.15e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMS—breast cancer	2.85e-06	4.11e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A1—breast cancer	2.84e-06	4.09e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—breast cancer	2.84e-06	4.09e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.82e-06	4.06e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOR1—breast cancer	2.82e-06	4.06e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—breast cancer	2.82e-06	4.06e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.82e-06	4.06e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1B1—breast cancer	2.72e-06	3.92e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAV1—breast cancer	2.71e-06	3.91e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—breast cancer	2.7e-06	3.89e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—breast cancer	2.69e-06	3.87e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—breast cancer	2.67e-06	3.85e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.67e-06	3.84e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—breast cancer	2.66e-06	3.84e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ERCC2—breast cancer	2.65e-06	3.82e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—breast cancer	2.64e-06	3.8e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA1—breast cancer	2.6e-06	3.74e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—STK11—breast cancer	2.56e-06	3.69e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP19A1—breast cancer	2.56e-06	3.69e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—breast cancer	2.49e-06	3.59e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—breast cancer	2.47e-06	3.56e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COMT—breast cancer	2.38e-06	3.43e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—breast cancer	2.37e-06	3.41e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—breast cancer	2.36e-06	3.4e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—breast cancer	2.34e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—breast cancer	2.33e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ITPR1—breast cancer	2.33e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—breast cancer	2.3e-06	3.31e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAV1—breast cancer	2.3e-06	3.31e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—breast cancer	2.25e-06	3.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—breast cancer	2.24e-06	3.23e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NOS3—breast cancer	2.23e-06	3.21e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMS—breast cancer	2.2e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.2e-06	3.16e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.18e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOR1—breast cancer	2.18e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—breast cancer	2.18e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—breast cancer	2.17e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—breast cancer	2.15e-06	3.09e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—breast cancer	2.09e-06	3.02e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—breast cancer	2.08e-06	3e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—breast cancer	2.06e-06	2.97e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—breast cancer	2.06e-06	2.97e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NOS3—breast cancer	2.05e-06	2.95e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ERCC2—breast cancer	2.05e-06	2.95e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—breast cancer	2.04e-06	2.94e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—breast cancer	1.92e-06	2.77e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—breast cancer	1.89e-06	2.73e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—breast cancer	1.88e-06	2.7e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—breast cancer	1.84e-06	2.65e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—breast cancer	1.83e-06	2.64e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—breast cancer	1.82e-06	2.62e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—breast cancer	1.78e-06	2.56e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAV1—breast cancer	1.77e-06	2.55e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NOS3—breast cancer	1.74e-06	2.5e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—breast cancer	1.64e-06	2.36e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—breast cancer	1.62e-06	2.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—breast cancer	1.62e-06	2.33e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—breast cancer	1.6e-06	2.31e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—breast cancer	1.59e-06	2.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—breast cancer	1.42e-06	2.05e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—breast cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—breast cancer	1.39e-06	2e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NOS3—breast cancer	1.34e-06	1.93e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—breast cancer	1.33e-06	1.91e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—breast cancer	1.26e-06	1.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—breast cancer	1.24e-06	1.78e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—breast cancer	1.23e-06	1.77e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—breast cancer	1.15e-06	1.66e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—breast cancer	1.07e-06	1.54e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—breast cancer	1.03e-06	1.48e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—breast cancer	9.78e-07	1.41e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—breast cancer	9.43e-07	1.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—breast cancer	7.99e-07	1.15e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—breast cancer	7.55e-07	1.09e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—breast cancer	6.17e-07	8.88e-06	CbGpPWpGaD
